Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $505.6 million.

  • Collegium Pharmaceutical's Non-Current Debt fell 1062.95% to $505.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.6 million, marking a year-over-year decrease of 1062.95%. This contributed to the annual value of $550.7 million for FY2024, which is 14839.91% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Non-Current Debt stood at $505.6 million for Q3 2025, which was down 1062.95% from $520.6 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Non-Current Debt peaked at $565.7 million during Q3 2024, and registered a low of $61.7 million during Q4 2021.
  • Its 5-year average for Non-Current Debt is $332.2 million, with a median of $353.8 million in 2023.
  • Per our database at Business Quant, Collegium Pharmaceutical's Non-Current Debt surged by 54472.81% in 2022 and then crashed by 5713.27% in 2024.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Non-Current Debt stood at $61.7 million in 2021, then soared by 544.73% to $397.6 million in 2022, then tumbled by 44.23% to $221.7 million in 2023, then skyrocketed by 148.4% to $550.7 million in 2024, then dropped by 8.2% to $505.6 million in 2025.
  • Its Non-Current Debt was $505.6 million in Q3 2025, compared to $520.6 million in Q2 2025 and $535.7 million in Q1 2025.